MedPath
FDA Approval

Tobramycin

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
July 27, 2018
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Tobramycin(3 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Medsource Pharmaceuticals

Medsource Pharmaceuticals

833685915

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tobramycin

Product Details

NDC Product Code
45865-427
Application Number
ANDA062535
Marketing Category
ANDA (C73584)
Route of Administration
OPHTHALMIC
Effective Date
July 27, 2018
Code: VZ8RRZ51VKClass: ACTIBQuantity: 3 mg in 1 mL
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7Class: IACT
BORIC ACIDInactive
Code: R57ZHV85D4Class: IACT
SODIUM SULFATEInactive
Code: 0YPR65R21JClass: IACT
TYLOXAPOLInactive
Code: Y27PUL9H56Class: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
SULFURIC ACIDInactive
Code: O40UQP6WCFClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath